Clinical Trial Participants Stuck in Coronavirus Vaccine Limbo

July 12, 2021

(Axios) – Tens of thousands of Americans who stepped up to help test coronavirus vaccines through clinical trials are now stuck without a standard vaccine card to prove it. State of play: Two vaccine candidates — created by Novavax and AstraZeneca, respectively — have clinical trial data suggesting they’re effective, but have yet to be authorized for use in the U.S. That leaves clinical trial participants in a potentially tough spot. (Read Full Article)